Molecular Templates Inc (MTEM)

[Digra Ive]

Phase 2 - TH-CR-601 Study for Treatment of Patients With EGFR Mutant, T790M-negative NSCLC (TH-4000)
Recruiting Australians and Americans patients.
Estimated Enrollment: 37
Study Start Date: June 2015
Estimated Study Completion Date: December 2016
Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)